AI Content Marketing for Biotech & Pharma

The Content Marketing challenge for Biotech & Pharma

The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.

On Content Marketing specifically, Biotech & Pharma teams run into: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute

How CoMo's Content Marketing Agent runs Content Marketing for Biotech & Pharma

AI drafts, scores, and schedules content 10x faster than a human team, enabling consistent publishing cadence without agency spend. The agent reads SEO Agent brief queue (topics, target keywords, comp examples), GA4 (page views, time-on-page, scroll depth, conversion rate by post), CMS draft history (Contentful / Sanity / WordPress), Brand voice guidelines and style guide and runs: Ingest content briefs from SEO Agent and convert them into full draft articles; Score each draft against readability, brand voice, E-E-A-T signals, and keyword density targets; Repurpose long-form posts into derivative assets: social snippets, email teasers, LinkedIn carousels; Manage editorial calendar: assign slots, track drafts-in-progress, flag overdue pieces; Run a freshness audit and queue evergreen posts for refresh when traffic declines >20%; A/B test headlines and meta descriptions, report winner lift — applied to Biotech & Pharma context.

For Biotech & Pharma that means coordinated execution across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships without adding headcount, with a human approval gate before anything publishes or spends.

What you get

Outputs: Published blog posts, landing pages, and pillar pages, Content calendar (30-day rolling, Notion or Airtable), Derivative asset pack per hero post (social, email, LinkedIn), Monthly content performance scorecard — tuned to Biotech & Pharma buyers (VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma) and moving Content-attributed organic traffic (sessions/month), Lead-gen conversions from content (form fills, demo requests), Content freshness ratio (% posts updated in last 6 months). The Content Marketing Agent works alongside CoMo's other agents so Content Marketing stays aligned with the rest of your marketing.

RELATED